BNET Industries

Neose Technologies Inc.

(NTEC) is in the Pharma Industry

Market Cap:$4.9M
Last Fiscal Year Sales:$8.8M
  • Public
  • US
Dow Jones Description

In accordance with a Plan of Complete Liquidation and Distribution (the "Plan of Liquidation") approved by its stockholders on January 26, 2009, Neose Technologies, Inc. filed a Certificate of Dissolution with the Secretary of State of the State of Delaware on March 2, 2009. The Company is no longer engaged in any business activities, except to the extent necessary to preserve the value of its assets, satisfy its remaining contractual obligations, and distribute its assets in accordance with the Plan of Liquidation. For more information on the Plan of Liquidation, please see the Company's Definitive Proxy Statement filed with the Securities and Exchange Commission on December 17, 2008, and subsequent filings available at www.sec.gov.

Executive Vice President & Chief Scientific Officer
David Zopf
Number of Employees 30
Contact Information

102 Rock Rd

Horsham, Pennsylvania 19044

neose.com

(215) 315-9000

NAICS Code Medicinal and Botanical Manufacturing: 325411

News & Analysis

neose technologies inc. - All News and Analysis

Decision Makers

Name (plus bio) Position
David Zopf Executive Vice President & Chief Scientific Officer
Joseph Villafranca Executive Vice President, Pharmaceutical Development
Debra Poul General Counsel & Senior Vice President
Chester A. Myers Vice President, Pharmaceutical Dev
Marjorie Hurley Vice President, Regulatory Affairs
W. Kevin Pelin Vice President, Manufacturing
Kevin C Tang
Wendy Nagy Assoc General Counsel

Board of Directors

Name (plus bio) Position
A. Brian Davis Board of Directors
David James Board of Directors
Elizabeth H.S. Wyatt Board of Directors
Henrik Clausen Board of Directors
Howard L Levine Board of Directors
James C Paulson Board of Directors
Lowell Sears Board of Directors
Richard D Cummings Board of Directors
Sandy Keller Board of Directors
Stewart Parker Board of Directors

Organization Position Status
Immune Control Inc Chief Scientific Officer Current
Neose Technologies, Inc. Executive Vice President & Chief Scientific Officer Current
Washington University School of Medicine M.D. Former
Washington University M.D. Degrees Former
Washington University A.B. in zoology Former

Organization Position Status
Tunnell Consulting, Inc. Senior Vice President, Operations Current
Tunnell Consulting, Inc. Practice Director Current
Tunnell Consulting, Inc. Principal Current
Dyadic International, Inc. Current
ImmunoGen, Inc. Board of Directors Current
Neose Technologies, Inc. Executive Vice President, Pharmaceutical Development Former
Bristol-Myers Squibb Company Vice President of Biologics Strategy and Biopharmaceuticals Operations Former
Purdue University Ph.D. in Biochemistry, Chemistry Former
The State University of New York B.S. in Chemistry Former

Organization Position Status
Neose Technologies, Inc. General Counsel & Senior Vice President Current
Villanova University law degree Former

Organization Position Status
Neose Technologies, Inc. Vice President, Pharmaceutical Dev Current

Organization Position Status
Neose Technologies, Inc. Vice President, Regulatory Affairs Current

Organization Position Status
Neose Technologies, Inc. Vice President, Manufacturing Current

Organization Position Status
Neose Technologies, Inc. Current

Organization Position Status
Neose Technologies, Inc. Assoc General Counsel Current

Organization Position Status
Neose Technologies, Inc. Board of Directors Current
Wharton Graduate School of the University of Pennsylvania MBA Former
The College of New Jersey B.S. In Accounting Former

Organization Position Status
Neose Technologies, Inc. Board of Directors Current

Elizabeth H.S. Wyatt has been a director since March 2005. Prior to her retirement in 2000, Ms. Wyatt held several senior positions at Merck & Co., Inc., a pharmaceutical company, over the course of 20 years, including most recently, Vice President, Corporate Licensing. Previously she had been a consultant and academic administrator, responsible for the Harvard Business School’s first formal marketing of its executive education programs. She also serves as a member of the Board of Sweet Briar College and recently chaired the Search Committee for the next President of Sweet Briar College. Ms. Wyatt received a B.A. from Sweet Briar College, a M.Ed. from Boston University and an M.B.A. from Harvard Business School.

Organization Position Status
The Medicines Company Independent Director, Member of Audit Committee and Chair of Compensation Committee Current
Angiox Independent Director, Member of Audit Committee and Chair of Compensation Committee Current
The Medicines Company Board of Directors Current
Medlmmune Ventures, Inc. Director Current
ARIAD Pharmaceuticals, Inc. Board of Directors Current
Randolph-Macon College Board of Trustees Current
Seabury Group LLC Director Current
Norwood Abbey Ltd Board of Directors Current
Sweet Briar College Board of Directors Current
Neose Technologies, Inc. Board of Directors Current
Merck & Co. Inc. Vice President, Corporate Licensing Former
Boston University M.S. In Education Former
Harvard Business School M.B.A. Former
Harvard Business School M.B.A. Former
The Medicines Company A.B. Former
Sweet Briar College A.B. Former

Organization Position Status
Neose Technologies, Inc. Board of Directors Current

Howard L. Levine, Ph.D., has over 20 years of experience in the biopharmaceutical industry. Prior to founding Bioprocess Technology Consultants to provide process development, manufacturing, quality control and quality assurance assistance to biopharmaceutical clients, Dr. Levine was Vice President of Manufacturing Operations at Repligen Corporation. He holds a Ph.D. in Chemistry from the University of Chicago and completed a post-doctoral fellowship at Harvard University.

Organization Position Status
Torreyana Gmp Biopharmaceutical Manufacturing Facility President Current
Bioprocess Technology Consultants, Inc. President Current
Asepco, Inc. Specialist Current
Acretia, Inc Current
Neose Technologies, Inc. Board of Directors Current
Pharmsource Information Services, Inc. Board of Directors Current
Repligen Corporation Vice President of Manufacturing Operations Former
XOMA Corporation Director Former
University of Chicago Ph.D. In Chemistry Former
Neose Technologies, Inc. member Former

Organization Position Status
Neose Technologies, Inc. Board of Directors Current
Cytel Inc Chief Scientific Officer Former
Cytel Inc Vice President of Research Former

Organization Position Status
Sears Capital Management, Inc. Chief Executive Officer Current
Coapt Systems, Inc. Current
Intekrin Therapeutics, Inc. Chairman of the Board Current
Sears Capital Management, Inc. Chairman Current
Neose Technologies, Inc. Board of Directors Current
Novacea, Inc. Board of Directors Current
Amgen Inc. Chief Financial Officer Former
Sears Capital Management, Inc. Chief Investment Officer Current
Stanford University MBA Former
Claremont McKenna College BA In Economics Former

Organization Position Status
Neose Technologies, Inc. Board of Directors Current

Organization Position Status
Neose Technologies, Inc. Board of Directors Current
Neose Technologies, Inc. Director, HR, Admin Former

Organization Position Status
Neose Technologies, Inc. Board of Directors Current
University of Washington M.B.A. Former
advertisement
     NTEC $0.09 +0.01 (5.88% )
Intraday | 3 Month | 6 Month | 1 Year
Average Volume 252,719
Shares Outstanding 54.47M
Market Cap 4.9M
Year High 0.45
Year Low 0.03
Earnings Per Share N/A
P/E Ratio -
Dividend N/A
Yield N/A
IndustryTop Rated
advertisement